Hällgren R
Scand J Clin Lab Invest. 1979 Sep;39(5):441-7. doi: 10.3109/00365517909106129.
The concentration of beta 2-microglobulin in serum was determined in seventy-one patients with various liver disorders. Elevated values were found in most patients with chronic active or chronic persistent hepatitis and in over 80% of patients with alcohol-induced liver cirrhosis. In contrast, patients with alcohol-induced fatty liver, the serum beta 2-microglobulin concentrations were mostly within the normal range. Significant correlation (P less than 0.001) was noted between the elimination rate of galactose from blood and the serum beta 2-microglobulin concentration in patients with alcoholic liver damage but not in patients with chronic hepatitis. The reasons for the increased S-beta 2-microglobulin concentrations in liver diseases are unknown. Several explanations including a release of beta 2-microglobulin from necrotic liver cells or an increased synthesis of beta 2-microglobulin consequent to inflammation in the liver are possible. Alternatively, raised beta 2-microglobulin levels may reflect the hepatic synthesis during reparative growth.
测定了71例患有各种肝脏疾病患者血清中β2 -微球蛋白的浓度。在大多数慢性活动性或慢性持续性肝炎患者以及超过80%的酒精性肝硬化患者中发现其值升高。相比之下,酒精性脂肪肝患者的血清β2 -微球蛋白浓度大多在正常范围内。在酒精性肝损伤患者中,血液中半乳糖清除率与血清β2 -微球蛋白浓度之间存在显著相关性(P小于0.001),而在慢性肝炎患者中则无此相关性。肝脏疾病中血清β2 -微球蛋白浓度升高的原因尚不清楚。几种解释包括β2 -微球蛋白从坏死肝细胞中释放出来,或者由于肝脏炎症导致β2 -微球蛋白合成增加。另外,升高的β2 -微球蛋白水平可能反映修复性生长过程中的肝脏合成情况。